Design
Review
Authors
Loading...
PFA-100 may guide select clinical hemostasis assessments with caution; leaves open need for specificity improvements and prospective validation.
The PFA-100 is a simple and sensitive tool for investigating primary hemostasis, screening for bleeding disorders, and monitoring antiplatelet therapy, though it lacks specificity.
Emmanuel J. Favaloro (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: